ALNY vs INSM: stock comparison and AI forecast
Alnylam Pharmaceuticals, Inc. (ALNY) and Insmed Inc (INSM) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALNY Alnylam Pharmaceuticals, Inc.
- Price
- $159.89 -46.9% · 6M
- Market Cap
- $21.42B
- P/E Ratio
- 7.5x
- Size
- large-cap
- AI Forecast
INSM Insmed Inc
- Price
- $109.31 -21.9% · 6M
- Market Cap
- $23.87B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- INSM is 1.1 times larger than ALNY by market capitalization ($23.87B against $21.42B).
- Over the last six months INSM returned -21.9% and ALNY -46.9%.
- ALNY turns 44.2% of its revenue into net income, against -39.9% for INSM.
- INSM carries 2.07 times debt per unit of equity, against 1.22 times for ALNY.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALNY | INSM |
|---|---|---|
| Market Cap | $21.42B | $23.87B |
| P/E Ratio | 7.52x | – |
| P/B Ratio | 5.94x | 32.87x |
| EPS | $21.27 | $-2.01 |
| Book Value/Share | $26.91 | $3.33 |
| Revenue/Share | – | $6.96 |
| FCF/Share | – | $-2.87 |
Profitability & Margins
| Metric | ALNY | INSM |
|---|---|---|
| ROE | 76.8% | -83.4% |
| ROA | 34.6% | -27.2% |
| ROIC | 22.7% | -34.6% |
| Gross Margin | 78.7% | 84.4% |
| Operating Margin | 21.5% | -37.1% |
| Net Margin | 44.2% | -39.9% |
| EBT Margin | 17.5% | -39.4% |
| Tax Rate | -174.3% | -1.3% |
Financial Health
| Metric | ALNY | INSM |
|---|---|---|
| Current Ratio | 2.48x | 2.86x |
| Quick Ratio | 2.43x | 2.59x |
| D/E Ratio | 1.22x | 2.07x |
| Financial Leverage | 2.22x | 3.07x |
| Interest Coverage | 4.7x | -6.7x |
| Working Capital | $3.05B | $1.11B |
Cash Flow
| Metric | ALNY | INSM |
|---|---|---|
| Operating Cash Flow | $1.23B | -$596M |
| Free Cash Flow | – | -$628M |
| Capital Spending | – | -$32M |
| FCF/Sales | – | -41.3% |
| CapEx/Sales | – | 2.1% |
Operational Efficiency
| Metric | ALNY | INSM |
|---|---|---|
| Asset Turnover | – | 0.68x |
| Receivables Turnover | – | 5.9x |
| Inventory Turnover | 12.6x | 1.4x |
| Fixed Assets Turnover | – | 14.0x |
| Days Sales Outstanding | – | 62 days |
| Days Inventory | 29 days | 252 days |
| Payables Period | 37 days | 130 days |
| Cash Conversion Cycle | – | 185 days |
Income Statement
| Metric | ALNY | INSM |
|---|---|---|
| Total Revenue | – | $1.52B |
| Operating Income | $1.35B | -$564M |
| Net Income | $2.77B | -$606M |
| R&D Expense | $1.92B | $944M |
| SG&A Expense | $1.66B | $960M |
| Cost of Goods Sold | $1.33B | $237M |
Dividend & Shareholder Information
| Metric | ALNY | INSM |
|---|---|---|
| Shares Outstanding | 134M | 218M |
ALNY vs INSM: stock comparison and AI forecast
Which is bigger, ALNY or INSM?
INSM is 1.1 times larger than ALNY by market capitalization ($23.87B against $21.42B).
Which stock performed better over the last six months, ALNY or INSM?
Over the last six months INSM returned -21.9% and ALNY -46.9%.
Which one does Intratio's AI model rank higher, ALNY or INSM?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.